Ligand Pharmaceuticals Inc (NASDAQ:LGND)

51.75
Data as of Aug 21
 -2.42 / -4.47%
Today’s Change
39.75
Today|||52-Week Range
80.42
-1.62%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$1.1B

Company Description

Ligand Pharmaceuticals, Inc. is a biopharmaceutical company with a business model that is based upon the concept of developing or acquiring royalty revenue generating assets and coupling them to a lean corporate cost structure. Its products address the unmet medical needs of patients for a broad spectrum of diseases, including hepatitis, muscle wasting, alzheimer's disease, dyslipidemia, diabetes, anemia, asthma, rheumatoid arthritis and osteoporosis. The company operates its business through two segments: CyDex and Ligand. The CyDex segment engages in development and commercialization of drugs using Captisol technology by CyDex Pharmaceuticals, Inc. The Ligand segment engages in developing or acquiring royalty revenue generating assets. Ligand Pharmaceuticals was founded by Ronald M. Evans in 1987 and is headquartered in La Jolla, CA.

Contact Information

Ligand Pharmaceuticals, Inc.
11119 North Torrey Pines Road
La Jolla California 92037
P:(858) 550-7500
Investor Relations:
(581) 550-7584

Employees

Shareholders

Other institutional54.51%
Mutual fund holders48.38%
Individual stakeholders19.70%

Top Executives

John L. HigginsPresident, Chief Executive Officer & Director
Matthew W. FoehrChief Operating Officer & Executive Vice President
Nishan M. de SilvaChief Financial Officer & Vice President-Strategy
Charles S. BerkmanSecretary, Vice President & General Counsel
Glenn DouradoDirector-Business Development

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.